Thrombocytopenia
273 results
201 - 273Adder (Vipera berus) bite
Infections in immunosuppressed and cancer patients
Bacterial diseases in warm climates
Heparin for the treatment of thrombosis in neonates
Pentasaccharides for the treatment of deep vein thrombosis
Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer
Treatment of newly diagnosed glioblastoma in the elderly: a network meta‐analysis
Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia
Anticoagulants for people hospitalised with COVID‐19
Gemcitabine‐based chemotherapy for advanced biliary tract carcinomas
Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer
Heparin versus normal saline for patency of arterial lines
Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C
Low molecular weight heparins for acute coronary syndromes
Myelodysplastic syndromes (MDS)
Interventions for atypical haemolytic uraemic syndrome
Cooling for newborns with hypoxic ischaemic encephalopathy
Comparison of first‐line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma
Erythropoietin or darbepoetin for patients with cancer
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
Hydroxyurea for reducing blood transfusion in non‐transfusion dependent beta thalassaemias
Linezolid versus vancomycin for skin and soft tissue infections
Thrombopoietin mimetics for patients with myelodysplastic syndromes: Cochrane systematic review
Heparin-bonded catheters for prolonging the patency of central venous catheters in children: Cochrane systematic review
Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery
Viral diseases in warm climates
Systemic lupus erythematosus (SLE)
Susceptibility to infections in adults
Mycophenolic acid for kidney transplant recipients
Prevention of venous thromboembolism
Early introduction of lipids to parenterally‐fed preterm infants
Interleukin 2 receptor antagonists for kidney transplant recipients: Cochrane systematic review
Heparin for assisted reproduction
Evaluation of thrombophilia
Indications for and implementation of anticoagulant therapy in atrial fibrillation
Recurrent infections and immunodeficiencies in children
Acute leukaemias in adults
Parenteral anticoagulation in ambulatory patients with cancer
Quinine for muscle cramps
Bortezomib for the treatment of multiple myeloma: Cochrane systematic review
Leucopenia
Peptic ulcer disease, Helicobacter pylori infection and chronic gastritis
Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis): Cochrane systematic review
Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients
Interleukin‐2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission
Best first‐line therapy for people with advanced non‐small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status
Interferon alpha for chronic hepatitis D
Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia: Cochrane systematic review
Anti‐epidermal growth factor receptor therapy for glioblastoma in adults
Platinum‐based chemotherapy for early triple‐negative breast cancer
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders: Cochrane systematic review
Aerobic physical exercise for adult patients with haematological malignancies
Lower leg dermatitis
Transfusion thresholds for guiding red blood cell transfusion
Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
Pentasaccharides for the prevention of venous thromboembolism: Cochrane systematic review
Cyclophosphamide for connective tissue disease–associated interstitial lung disease
Postinfectious syndromes
Linezolid for drug‐resistant pulmonary tuberculosis
Foetal haemoglobin inducers for reducing blood transfusion in non‐transfusion‐dependent beta‐thalassaemias
Acute coronary syndrome
Deep vein thrombosis
Exanthem (eruptive skin rash)